Treatment of adolescent tobacco smokers: Issues and opportunities for exposure reduction approaches

Drug and Alcohol Dependence

Volumn 70, Issue 3, 2003, Pages 223-232

  Moolchan, Eric T ^a,d   Aung, A Thiri ^a   Henningfield, Jack E ^b,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PINNEY ASSOCIATES   (United States)

^d Clin Pharmacol Therapeut Res Br   (United States)

Author keywords

Adolescents; Exposure reduction; Policy; Smoking; Tobacco; Treatment

Indexed keywords

BIOLOGICAL MARKER;

EXPOSURE; MOTIVATION; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE; REVIEW; SMOKING CESSATION; SMOKING HABIT; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; TOBACCO;

NICOTIANA TABACUM;

EID: 0038325712     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00012-7     Document Type: Review

References (88)

1. Adelman W.P., Duggan A.K., Hauptman P., Joffe A. Effectiveness of a high school smoking cessation program. Pediatrics. 107:2001;E50.
2. Aung, A.T., Epstein, D.H., Thatte, N., Cadet, J.L., Ernst, M., Moolchan, E.T., 2002. Psychiatric and Smoking Correlates in Adolescent Smokers. Society for Research on Nicotine and Tobacco Eighth Annual Scientific Conference: Savannah.
3. Bartecchi C.E., MacKenzie T.D., Schrier R.W. The human costs of tobacco use. N. Engl. J. Med. 330:1994;907-912.
4. Benowitz N.L., Perez-Stable E.J., Fong I., Modin G., Herrera B., Jacob P. 3rd. Ethnic differences in N-glucurinoidation of nicotine and cotinine. Journal of Pharmacology and Experimental Therapeutics. 291:1999;1196-1203.
5. Benowitz, N.L., Ahijevych, K., Hall, S., Hansson, A., Henningfield, J., Hurt, R.D., Jacob III, P., Jarvis, M.J., LeHouezec, J., Lichtenstein, E., Tsoh, J., Velicer, W. Biochemical verification of tobacco use and cessation. SRNT Subcommittee on Biochemical Verification. Nicotine Tob. Res., in press.
6. Bolliger C.T., Zellweger J.P., Danielsson T., van Biljon X., Robidou A., Westin A., Perruchoud A.P., Sawe U. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. Br. Med. J. 321:2000;329-333.
7. Breslau N., Kilbey M., Andreski P. Nicotine dependence, major depression and anxiety in young adults. Arch. Gen. Psychiatry. 48:1991;1069-1074.
8. Breslau N., Kilbey M.M., Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am. J. Psychiatry. 149:1992;464-469.
9. Breslau N. Daily cigarette consumption in early adulthood: age of smoking initiation and duration of smoking. Drug Alcohol Depend. 33:1993;287-291.
10. Centers for Disease Control and Prevention, 1994. Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users - United States, 1993. MMWR Morb. Mortal. Wkly. Rep. 43, 745-750.
11. Chassin L., Presson C., Sherman S., Edwards D. The natural history of cigarette smoking: predicting young adult smoking from adolescent smoking patterns. Health Psychol. 9:1990;701-716.
12. Colby S.M., Monti P.M., Barnett N.P., Rohsenow D.J., Weissman K., Spirito A., Woolard R.H., Lewander W.J. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. J. Consult. Clin. Psychol. 66:1998;574-578.
13. Colby S.M., Tiffany S.T., Shiffman S., Niaura R.S. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend. 59:(Suppl. 1):2000;S83-S95.
14. Colletti G., Supnick J.A., Rizzo A.A. Long-term follow-up (3-4 years) of treatment for smoking reduction. Addict. Behav. 7:1982;429-433.
15. Covey L.S., Glassman A.H., Stetner F., Becker J. Effect of history of alcoholism or major depression on smoking cessation. Am. J. Psychiatry. 150:1993;1546-1547.
16. Dahl R.E. Affect regulation, brain development, and behavioral/emotional health in adolescence. CNS Spectrums. 6:2001;60-72.
17. DiFranza J.R., Savageau J.A., Fletcher K., Ockene J.K., Rigotti N.A., McNeill A.D., Coleman M., Wood C. Measuring the loss of autonomy over nicotine use in adolescents: The DANDY (Development and Assessment of Nicotine Dependence in Youths) Study. Arch. Pediatr. Adolesc. Med. 156:2002;397-403.
18. Djordjevic M.V., Hoffmann D., Hoffmann I. Nicotine regulates smoking patterns. Prev. Med. 26:1997;435-440.
19. Doll R., Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J. Epidemiol. Commun. Health. 32:1978;303-313.
20. Eissenberg T., Balster R.L. Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug Alcohol Depend. 59:(Suppl 1):2000;S41-S60.
21. Eliasson B., Hjalmarson A., Kruse E., Landfeldt B., Westin A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob. Res. 3:2001;249-255.
22. Engels R.C., Knibbe R.A., de Vries H., Drop M.J. Antecedents of smoking cessation among adolescents: who is motivated to change? Prev. Med. 27:1998;348-357.
23. Ernst M., Moolchan E.T., Robinson M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J. Am. Acad. Child Adolesc. Psychiatry. 40:2001;630-641.
24. Etter J., Laszlo E., Zellweger J., Perrot C., Perneger T.V. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. J. Clin. Pharmacol. 22:2002;487-495.
25. Fagerström K.O., Tejding R., Westin A., Lunell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tob. Control. 6:1997;311-316.
26. Farrelly M., Niederdeppe J., Yarsevich J. Future directions in tobacco countermarketing mass media compaigns, Tob. Control, in press.
27. Fiore M.C. US public health service clinical practice guideline: treating tobacco use and dependence. Respir. Care. 45:2000;1200-1262.
28. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., Alexoff D., MacGregor R.R., Schlyer D.J., Zezulkova I., Wolf A.P. Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. USA. 93:1996;14065-14069.
29. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 379:1996;733-736.
30. Glasgow R., Morray K., Lichtenstein E. Controlled smoking versus abstinence as a treatment goal: the hopes and fears may be unfounded. Behav. Ther. 0:1989;77-91.
31. Glassman A.H. Cigarette smoking: implications for psychiatric illness. Am. J. Psychiatry. 150:1993;546-553.
32. Goodman E., Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics. 106:2000;748-755.
33. Henningfield J.E. Pharmacologic basis and treatment of cigarette smoking. J. Clin. Psychiatry. 45:1984;24-34.
34. Henningfield J.E., Goldberg S.R. Progress in understanding the relationship between the pharmacological effects of nicotine and human tobacco dependence. Pharmacol. Biochem. Behav. 30:1988;217-220.
35. Henningfield J.E., Slade J. Tobacco-dependence medications: public health and regulatory issues. Food Drug Law J. 53:1998;75-114.
36. Henningfield J.E., Michaelides T., Sussman S. Developing treatment for nicotine addicted youth: issues and challenges. J. Child Adolesc. Subst. Abuse. 9:2000;5-26.
37. Herning R.I., Jones R.T., Benowitz N.L., Mines A.H. How a cigarette is smoked determines blood nicotine levels. Clin. Pharmacol. Ther. 33:1983;84-90.
38. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 143:1986;993-997.
39. Hughes J.R. Environmental determinants of the reinforcing effects of nicotine in humans. J. Subst. Abuse Treat. 1:1989;319-329.
40. Hughes J. Applying harm reduction to smoking. Tob. Control. 4:1995;S33-S38.
41. Hughes J.R., Cummings K.M., Hyland A. Ability of smokers to reduce their smoking and its association with future smoking cessation. Addiction. 94:1999;109-114.
42. Hurt R.D., Croghan G.A., Beede S.D., Wolter T.D., Croghan I.T., Patten C.A. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Arch. Pediatr. Adolesc. Med. 154:2000;31-37.
43. Hurt R.D., Croghan G.A., Wolter T.D., Croghan I.T., Offord K.P., Williams G.M., Djordjevic M.V., Richie J.P. Jr., Jeffrey A.M. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob. Res. 2:2000;327-336.
44. Johnson J.G., Cohen P., Pine D.S., Klein D.F., Kasen S., Brook J.S. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA. 284:2000;2348-2351.
45. Kandel D.B., Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob. Res. 2:2000;263-274.
46. Kawachi I., Colditz G.A., Speizer F.E., Manson J.E., Stampfer M.J., Willett W.C., Hennekens C.H. A prospective study of passive smoking and coronary heart disease. Circulation. 95:1997;2374-2379.
47. Kelly J.F., Myers M.G., Brown S.A. A multivariate process model of adolescent 12-step attendance and substance use outcome following inpatient treatment. Psychol. Addict. Behav. 14:2000;376-389.
48. Khuder S.A., Dayal H.H., Mutgi A.B. Age at smoking onset and its effect on smoking cessation. Addict. Behav. 24:1999;673-677.
49. Klein J.D., Levine L.J., Allan M.J. Delivery of smoking prevention and cessation services to adolescents. Arch. Pediatr. Adolesc. Med. 155:2001;597-602.
50. Levin E.D., Conners C.K., Silva D., Hinton S.C., Meck W.H., March J., Rose J.E. Transdermal nicotine effects on attention. Psychopharmacology (Berl.). 140:1998;135-141.
51. MacCoun R., Reuter P. Evaluating alternative cannabis regimes. Br. J. Psychiatry. 78:2001;123-128.
52. McCormick L.K., Crawford M., Anderson R.H., Gittelsohn J., Kingsley B., Upson D. Recruiting adolescents into qualitative tobacco research studies: experiences and lessons learned. J. School Health. 69:1999;95-99.
53. McNeill A.D., Jarvis M., West R. Subjective effects of cigarette smoking in adolescents. Psychopharmacology. 92:1987;115-117.
54. Mermelstein R., Colby S.M., Patten C., Prokhorov A., Brown R., Myers M., Adelman W., Hudmon K., McDonald P. Methodological issues in measuring treatment outcome in adolescent smoking cessation studies. Nicotine Tob. Res. 4:2002;395-403.
55. Moolchan E.T., Ernst M., Henningfield J.E. A review of tobacco smoking in adolescents: treatment implications. J. Am. Acad. Child Adolesc. Psychiatry. 39:2000;682-693.
56. Moolchan E.T., Ruckel S.J. Tobacco cessation for adolescents: developing a group therapy approach. J. Child Adolesc. Subst. Abuse. 4:2002;395-403.
57. Moolchan E.T., Mermelstein R. Research on tobacco use among teenagers: ethical challenges. J. Adolesc. Health. 30:(6):2002;409-417.
58. National Cancer Institute, 2001. Risks associated with smoking cigarettes with low-machine measured yields of tar and nicotine. Smoking and Tobacco Control Monograph No. 13. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institutes, NIH Pub. No. 02-5074.
59. O'Brien C.P., McLellan A.T. Addiction medicine. JAMA. 277:1997;1840-1841.
60. Orleans T. Treating nicotine dependence in medical settings: a stepped care model. Orleans C.T., Slade J. Nicotine Addiction: Principles and Management. 1993;145-161 Oxford University Press, New York.
61. Orleans C.T., Johnson R.W., Barker D.C., Kaufman N.J., Marx J.F. Helping pregnant smokers quit: meeting the challenge in the next decade. West. J. Med. 174:2000;276-281.
62. Pallonen U.E. Transtheoretical measures for adolescent and adult smokers: similarities and differences. Prev. Med. 27:1998;A29-A38.
63. Patton G.C., Hibbert M., Rosier M.J., Carlin J.B., Caust J., Bowes G. Is smoking associated with depression and anxiety in teenagers? Am. J. Public Health. 86:1996;225-230.
64. Pianezza M.L., Sellers E.M., Tyndale R.F. Nicotine metabolism defect reduces smoking. Nature. 393:1998;750.
65. Prokhorov A.V., Hudmon K.S., de Moor C.A., Kelder S.H., Conroy J.L., Ordway N. Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking. Nicotine Tob. Res. 3:2001;151-155.
66. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Br. Res. Rev. 18:1993;247-291.
67. Rojas N., Killen J., Haydel K., Robinson T. Nicotine dependence among adolescent smokers. Arch. Pediatr. Adolesc. Med. 152:1998;151-156.
68. Romer D., Jamieson P. Do adolescents appreciate the risks of smoking? Evidence from a national survey. J. Adolesc. Health. 29:2001;12-21.
69. Sargent J., Mott L., Stevens M. Predictors of smoking cessation in adolescents. Arch. Pediatr. Adolesc. Med. 152:1998;388-393.
70. Scherer G. Smoking behavior and compensation: a review of the literature. Psychopharmacology. 145:1999;1-20.
71. Schmid H. Predictors of cigarette smoking by young adults and readiness to change. Subst. Use Misuse. 36:2001;1519-1542.
72. Sexton M., Hebel J.R. A clinical trial of change in maternal smoking and its effect on birth weight. JAMA. 251:1984;911-915.
73. Smith T.A., House R.F., Croghan I.T., Gauvin T.R., Colligan R.C., Offord K.P., Gomez-Dahl L.C., Hurt R.D. Nicotine patch therapy in adolescent smokers. Pediatrics. 98:1996;659-667.
74. Stein J.H., Bushara M., Bushara K., McBride P.E., Jorenby D.E., Fiore M.C. Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels. Clin. Cardiol. 25:2002;23-26.
75. Stratton K., Shetty P., Wallace R., Bondurant S. Clearing the smoke. 2001;National Academy Press, Washington, DC.
76. Sussman S. School-based tobacco use prevention and cessation: where are we going. Am. J. Health Behav. 25:2001;191-199.
77. Taioli E., Wynder E. Effect of the age at which smoking begins on frequency of smoking in adulthood. N. Engl. J. Med. 325:1991;968-969.
78. Thorndike A.N., Ferris T.G., Stafford R.S., Rigotti N.A. Rates of US physicians counseling adolescents about smoking. J. Natl. Cancer Inst. 91:1999;1857-1862.
79. Thun M.J., Heath C.W. Jr. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev. Med. 26:1997;422-426.
80. US Department of Health and Human Services, 1990. The health benefits of smoking cessation. A report of the Surgeon General. Washington, DC: US Government Printing Office.
81. US Department of Health and Human Services, 1994. Preventing tobacco use among young people. A report of the Surgeon General. Washington, DC: US Government Printing Office.
82. Volpicelli J.R., Volpicelli L.A., O'Brien C.P. Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. Alcohol Alcohol. 30:1995;789-798.
83. Wald N.J., Watt H.C. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. Br. Med. J. 314:1997;1860-1861.
84. Warner K.E., Peck C.C., Woosley R.L., Henningfield J.E., Slade J. Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface. Food Drug Law J. 53:(Suppl):1998;1-8.
85. West R.R. Smoking: its influence on survival and cause of death. J. Roy. Coll. Phys. Lond. 26:1992;357-366.
86. Windle M., Windle R.C. Depressive symptoms and cigarette smoking among middle adolescents: prospective associations and intrapersonal and interpersonal influences. J. Consult. Clin. Psychol. 69:2001;215-226.
87. Windsor R.A., Li C.Q., Boyd N.R. Jr., Hartmann K.E. The use of significant reduction rates to evaluate health education methods for pregnant smokers: a new harm reduction behavioral indicator? Health Educ. Behav. 26:1999;648-662.
88. World Bank, 1999. Curbing the epidemic: governments and the economics of tobacco control. Washington, DC: World Bank.